Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,156 GBX | -0.12% | +7.88% | +14.68% |
05:18pm | AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial | MT |
04:46pm | AstraZeneca: research into respiratory diseases | CF |
Evolution of the average Target Price on AstraZeneca PLC
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AstraZeneca PLC
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
JPMORGAN | James Gordon |
Barclays | |
UBS | Matthew Weston |
DZ BANK | Elmar Kraus |
alphavalue | Abhishek Raval |
JEFFERIES | Peter Welford |
BERNSTEIN RESEARCH | Justin Smith |
Deutsche Bank Securities | |
Bernstein | |
B. Riley | |
RBC Capital Markets | |
Berenberg Bank | |
BERENBERG | Luisa Hector |
BMO Capital | |
Stifel Nicolaus | |
Jefferies & Co. | |
CREDIT SUISSE | Dominic Lunn |
HSBC | |
Argus | |
Morgan Stanley | |
GOLDMAN SACHS | Keyur Parekh |
Bank of America Securities/Merrill Lynch | |
Danske Bank Group | |
Kepler Capital Markets | |
Kepler Cheuvreux | |
DEUTSCHE BANK | Emmanuel Papadakis |
SVB Leerink | |
Bryan, Garnier & Co. | |
Societe Generale | |
Liberum Capital | |
ODDO BHF | |
BANK OF AMERICA (BOFA) | Sachin Jain |
EPS Revisions
- Stock Market
- Equities
- AZN Stock
- Consensus AstraZeneca PLC